TITLE

Calvarial Tubercular Osteomvelitic Abscess

AUTHOR(S)
Rajesh, A.; Purohit, A. K.; Lakshmi, V.
PUB. DATE
October 2009
SOURCE
Indian Journal of Medical Microbiology;Oct2009, Vol. 27 Issue 4, p380
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents a case study of a 29-year-old male who demonstrated headache and scalp swelling over the left frontal region. The patient underwent a left fronto-temporal curvilinear incision, evacuation of pus, and removal of involved bone. A growth of mycobacterium tuberculosis was shown by the patient at the end of 5 weeks observation and testing allowing him to take drug anti-tubercular regime including rifampicin, ethambutol, and pyrazinamide.
ACCESSION #
44320270

 

Related Articles

  • Study of Stability of New Mutual Prodrugs with Antimycobacterial Activity. Jampilek, Josef; Reckova, Zuzana; Imramovsky, Ales; Raich, Ivan; Vinsova, Jarmila; Dohnal, Jiri // Current Organic Chemistry;May2008, Vol. 12 Issue 8, p667 

    New mutual prodrugs of pyrazinamide, isoniazid, p-aminosalicylic acid and ciprofloxacine were designed and synthesised. All the prepared compounds were tested for their antimycobacterial activities. Several discussed compounds showed excellent biological effects against both Mycobacterium...

  • The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Somoskovi, Akos; Parsons, Linda M.; Salfinger, Max // Respiratory Research;2001, Vol. 2, p164 

    Multidrug-resistant (MDR) strains of Mycobacterium tuberculosis have emerged worldwide. In many countries and regions, these resistant strains constitute a serious threat to the efficacy of tuberculosis control programs. An important element in gaining control of this epidemic is developing an...

  • Drug susceptibility pattern of Mycobacterium tuberculosis in adult patients with miliary tuberculosis. Irfan, Muhammad; Hussain, Syed Fayyaz; Jabeen, Kausar; Islam, Muhammad // Tropical Doctor;Jul2007, Vol. 37 Issue 3, p182 

    Miliary tuberculosis (TB) is a fatal form of TB. Although drug resistance in TB patients has increased worldwide, there is limited information on drug resistance in miliary TB. This study from Pakistan evaluated drug susceptibility pattern among miliary TB patients of a high TB-burden country....

  • Multidrug-Resistant Tuberculosis in Patients for Whom First-Line Treatment Failed, Mongolia, 2010-2011. Dobler, Claudia C.; Korver, Sarah; Batbayar, Ochirbat; Nyamdulam, Batiargal; Oyuntsetseg, Sodnomdarjaa; Tsolmon, Bold; Surmaajav, Bazarragchaa; Bayarjargal, Byambaa; Marais, Ben J. // Emerging Infectious Diseases;Aug2015, Vol. 21 Issue 8, p1451 

    In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear-positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired MDR TB and a need to make rapid molecular drug...

  • Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis. Srivastava, Shashikant // Lung India;Jul/Aug2015, Vol. 32 Issue 4, p402 

    The author discusses a study related to pharmacokinetics of anti-tuberculosis drugs published within the periodical. Topics discussed include monitoring of various drugs such as rifampin and pyrazinamide; standard minimum inhibitory concentration (MIC) of some strains of Mycobacterium...

  • Fluoroquinolones for the Treatment of Pulmonary Tuberculosis. Moadebi, Susanne; Harder, Curtis K.; Fitzgerald, Mark J.; Elwood, Kevin R.; Marra, Fawziah // Drugs;2007, Vol. 67 Issue 14, p2077 

    Tuberculosis (TB) continues to be a significant problem globally. Treatment includes a multiple drug regimen with isoniazid, rifampicin (rifampin), pyrazinamide and ethambutol. Often, one of these medications needs to be replaced as a result of adverse events or because Mycobacterium...

  • Identification of Five New Minor Constituents from the Whole Plant of Amischotolype hispida. Chang, Chun-Wei; Chen, Ih-Sheng; Chang, Hsun-Shuo; Cheng, Ming-Jen; Peng, Chien-Fang // Helvetica Chimica Acta;Mar2015, Vol. 98 Issue 3, p347 

    Bioassay-guided fractionation of the active AcOEt-soluble layer from the whole plant of Amischotolype hispida resulted in the isolation of four new compounds, i.e., amisbenzoic acid ( 1), one butenolide derivative, amisnolide ( 2), one chlorin analog, amisphytin ( 3), one lignan, amislignol (...

  • In-Depth Molecular Characterization of Mycobacterium tuberculosis from New Delhi - Predominance of Drug Resistant Isolates of the 'Modern' (TbD1-) Type. Stavrum, Ruth; Myneedu, Vithal Prasad; Arora, Virendra K.; Ahmed, Niyaz; Grewal, Harleen M. S. // PLoS ONE;2009, Vol. 4 Issue 2, p1 

    Background: India has the highest estimated burden of tuberculosis in the world, accounting for 21% of all tuberculosis cases world-wide. However, due to lack of systematic analysis using multiple markers the available information on the genomic diversity of Mycobacterium tuberculosis in India...

  • High Isoniazid Resistance Rates in Rifampicin Susceptible Mycobacterium tuberculosis Pulmonary Isolates from Pakistan. Fasih, Naima; Rafiq, Yasraba; Jabeen, Kausar; Hasan, Rumina // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: Rapid new diagnostic methods (including Xpert MTB/RIF assay) use rifampicin resistance as a surrogate marker for multidrug resistant tuberculosis. Patients infected with rifampicin susceptible strains are prescribed first line antituberculosis therapy. The roll out of such methods...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics